Lupin Limited has informed the Exchange regarding a press release dated December 25, 2021, titled "Lupin Receives Approval from U.S. FDA for Sevelamer Carbonate for Oral Suspension".
Lupin Limited has informed the Exchange regarding a press release dated December 25, 2021, titled "Lupin Receives Approval from U.S. FDA for Sevelamer Carbonate for Oral Suspension".